Community Statement: Biogen announces BRAVE Phase 3 Pediatric Study of Omaveloxolone
Industry News
Blog|May 5 2025
Meet the Community: Natalie Rex
Community
News|May 2 2025
April/May 2025 – Advocacy Newsletter
Advocacy
Blog|Apr 28 2025
Meet the Community: Paul Hardwick
Community
News|Apr 23 2025
Webinar Recording: Solid Biosciences April 2025 Update
FARA News | Industry News
Blog|Apr 22 2025
Participating in Research: Joe Tyler
Community
Blog|Apr 21 2025
Meet the Community: Sydni Dupre
Community
Blog|Apr 14 2025
2025 rideATAXIA Gainesville Recap
Events
News|Apr 9 2025
Press Release & Community Update: Lexeo Therapeutics Announces Positive Interim Phase 1/2 Data for LX2006 in Friedreich Ataxia Cardiomyopathy Supporting Advancement to Registrational Study